The treatment target for patients with giant cell arteritis or polymyalgia rheumatica should be remission, with vascular damage prevention taking priority in patients with GCA, according to treat-to-target recommendations from EULAR. “Treatment targets have already been defined in several areas of rheumatology, including rheumatoid arthritis (RA), spondyloarthritis (SpA), gout and systemic

CurvaFix Inc. received FDA 510(k) clearance of its CurvaFix IM implant for fixation of pelvic fractures in smaller patients, according to a press release.The CurvaFix implant is designed to address the common challenges surgeons face with pelvic fractures, such as dysmorphic sacra and curved superior rami, according to the release.

NuVasive Inc. has announced increased net sales and a record quarter for cervical net sales for its C360 portfolio in its third-quarter 2022 financial results, according to a company press release.The company reported $295.3 million in total net sales, which is a 12.9% increase on a constant currency basis compared with the third quarter of 2021. The company also reported a generally accepted